Companies › ICU
SEASTAR MEDICAL HOLDING CORP (ICU)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001831868 · EDGAR filings · Updated 2026-07-21
SEASTAR MEDICAL HOLDING CORP (ICU) has reported institutional ownership of 3.3%, with 10 institutional managers holding positions valued at $932.6K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-21 — Employee-plan registration (S-8) filed
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SEASTAR MEDICAL HOLDING CORP has 10 institutional holders and institutional ownership of 3.3%.
Insider activity
Insiders reported 26 transactions (9 buys, 0 sells) across 8 reporting insiders, with a net reported value of $82.0K.
Data flags from SEC filings
Related companies
Icecure Medical Ltd (ICCM) · JYONG BIOTECH LTD (MENS) · Beyond Air Inc (XAIR) · BIOAFFINITY TECHNOLOGIES INC (BIAF) · Citius Pharmaceuticals Inc (CTXR) · BULLFROG AI HLDGS INC (BFRG)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.